OTCMKTS:SEOVF Sernova Biotherapeutics (SEOVF) Stock Price, News & Analysis $0.08 0.00 (-0.37%) As of 10/9/2026 03:55 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsNews and TrendsSEC Filings About Sernova Biotherapeutics Stock (OTCMKTS:SEOVF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SEOVF alerts:Sign Up Key Stats Today's Range$0.08▼$0.0850-Day Range$0.06▼$0.1052-Week Range$0.06▼$0.14Volume3,358 shsAverage Volume144,305 shsMarket Capitalization$30.48 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Sernova Biotherapeutics is a clinical-stage biotechnology company developing regenerative medicine technologies designed to provide long-term treatment for chronic diseases. The company’s primary platform, the Cell Pouch System, is an implantable device intended to create a vascularized environment in the body where therapeutic cells can be placed and supported. Sernova has focused on cell-based therapies for conditions including type 1 diabetes, hemophilia A and thyroid disease. Its approach combines the Cell Pouch System with insulin-producing islet cells, blood-clotting factor-producing cells or other therapeutic cells, with the goal of restoring biological functions that are impaired by disease. The company has also explored technologies intended to protect transplanted cells from immune-system rejection and reduce or eliminate the need for chronic immunosuppressive drugs. Based in London, Ontario, Canada, Sernova has conducted research and clinical development activities in Canada and the United States. The company has been led by Dr. Philip Toleikis, who has served as president and chief executive officer. Its programs remain focused on advancing cell-based and regenerative therapies toward potential clinical applications.AI Generated. May Contain Errors. Read More Receive SEOVF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Sernova Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SEOVF Stock News HeadlinesSernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical TrialOctober 5, 2026 | globenewswire.comSernova Biotherapeutics Inc (SVA)September 25, 2026 | ca.investing.comTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered. Buried inside is what some call the legal groundwork for the biggest change to American money in over a century, with a key Treasury vote potentially as soon as January 18. Ian King, Chief Strategist at Strategic Fortunes, breaks down what the order could mean for the dollar and the financial system. | Banyan Hill Publishing (Ad)Sernova Biotherapeutics to Participate in Noble Capital Markets' Emerging Growth Virtual Equity ConferenceSeptember 25, 2026 | globenewswire.comSernova Biotherapeutics Inc SEOVFMay 14, 2026 | morningstar.comMSernova Biotherapeutics: Sernova Biotherapeutics Strengthens Balance Sheet with $7.1 Million in Financings Plus Net Retirement of a Cumulative $17 Million of Debt Subject to ...March 4, 2026 | finanznachrichten.deSernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical EffortsNovember 13, 2025 | finance.yahoo.comSernova Biotherapeutics Announces Collaboration with Eledon ...July 11, 2025 | morningstar.comMSee More Headlines SEOVF Stock Analysis - Frequently Asked Questions How have SEOVF shares performed this year? Sernova Biotherapeutics' stock was trading at $0.0943 at the start of the year. Since then, SEOVF stock has decreased by 14.4% and is now trading at $0.0807. How were Sernova Biotherapeutics' earnings last quarter? Sernova Biotherapeutics Inc. (OTCMKTS:SEOVF) issued its earnings results on Thursday, September, 10th. The company reported ($0.01) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by $0.00. How do I buy shares of Sernova Biotherapeutics? Shares of SEOVF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings9/10/2026Today10/10/2026Fiscal Year End10/31/2026Next Earnings (Estimated)12/18/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolOTCMKTS:SEOVF CIK1491434 Webwww.sernova.com Phone(519) 858-5184Fax519-858-5184EmployeesN/AYear Founded2006Profitability EPS (Trailing Twelve Months)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$11.24 million Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-1,111.49% Debt Debt-to-Equity RatioN/A Current Ratio0.03 Quick Ratio0.03 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($0.05) per share Price / Book-1.61Miscellaneous Outstanding Shares377,640,000Free FloatN/AMarket Cap$30.48 million OptionableNot Optionable Beta0.89 Social Links (Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.Get This Free Report This page (OTCMKTS:SEOVF) was last updated on 10/10/2026 by MarketBeat.com Staff. From Our PartnersThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredA Simple Guide to Options Trading While It's Still FreeA free copy of Options Trading Made Simple is available now but wont stay that way for long. Chris Rowe cal...True Market Insiders | SponsoredThis free guide explains options the way they should be taughtMost options educators jump straight into Greeks, spreads, and implied volatility - losing beginners before th...Base Camp Trading | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredThe only 5 stocks that matterSpaceX's IPO reportedly minted 4,400 new millionaires, and OpenAI is said to be eyeing a 1 trillion dollar IPO...TradeSmith | SponsoredTrump goes "all-in" on Grand Canyon energy breakthroughA drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...Behind the Markets | SponsoredA simple options setup that cuts through the noiseIan Cooper says most options traders overcomplicate the process, juggling countless indicators, strategies, an...TradeWins | SponsoredA weekly dividend fund holding Nvidia and PalantirCrowdStrike, Palantir, Nvidia none of them pay a real dividend. But one fund holding the biggest AI names dist...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sernova Biotherapeutics Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sernova Biotherapeutics With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SEOVF Stock Alerts